Single cell genome sequencing allows analyzing genetic material from individual cells. It helps understand heterogeneity at a single cell resolution. Single cell genome sequencing has applications in oncology, immunology, neuroscience and stem cell research. The technique helps understand cell development and cell-to-cell interactions.
The global single cell genome sequencing market is estimated to be valued at US$ 2.63 Mn in 2024 and is expected to exhibit a CAGR of 3.9% over the forecast period 2024 to 2030.
Advances in optics, microfluidics and sequencing technologies have revolutionized genomics at single cell level. Single cell sequencing techniques capture transcriptional profiles from thousands of cells simultaneously.This helps characterize population structures, trace developmental trajectories and identify rare cell types.
Key Takeaways
Key players operating in the single cell genome sequencing market are Logitech International SA, Microsoft Corporation, Datadesk Technologies, Inc., Fentek Industries Inc., Adesso AG, Shenzhen V4 Electronic Co., Ltd., Fellowes Limited, Kinesis Corporation, Gold Touch Enterprise Inc., and Posturite UK Ltd.
Growing demand for personalized medicine and precision medicine is a major factor driving the single Cell Genome Sequencing Market Trends Single cell analysis plays a vital role in developing targeted therapies by characterizing inter- and intra-tumoral heterogeneity. It helps develop customized treatment strategies. Growing incidence of cancer and infectious diseases is propelling demand for single cell genome sequencing techniques.
Technological advancements are expanding applications of single cell genome sequencing. Developments in microfluidics enable high throughput analysis of thousands of cells. Advanced next generation sequencing technologies provide high resolution genomic and epigenomic profiling at single cell level. Nanowell and droplet based microfluidics facilitate transcriptomic analysis of large number of cells.
Market Trends
Commercialization of integrated microfluidic systems for sequencing and analysis of thousands of cells at one go will drive the market. Emergence of cloud based platforms for computational analysis of massive single cell datasets generated is another key trend. Adoption of single cell multi-omics techniques integrating genomics, epigenomics, transcriptomics and proteomics at single cell level will expand applications. Growth in clinical applications of single cell sequencing techniques in oncology and infectious disease monitoring is expected to fuel revenues.
Market Opportunities
Technological development of low cost, portable and label free single cell analysis devices offers significant opportunities. Integration of microfluidics, optics and sequencing in portable lab-on-a-chip devices can facilitate point-of-care applications. Development of spatial transcriptomics techniques preserving spatial context of cells will augment clinical applications. Growing research in areas of immunology, neuroscience and developmental biology presents scope for market players.
Impact of COVID-19 on Single Cell Genome Sequencing Market growth
The COVID-19 pandemic has adversely impacted the single cell genome sequencing market growth. During the initial outbreak, supply chain disruptions and lockdowns caused delays in research activities and new product launches. This led to reduced demand for instruments, reagents and kits. However, with increasing research on virus genomics and mutations, single cell sequencing found widespread usage to study host-pathogen interactions and viral pathogenesis. Various research institutes and biotech firms are conducting single cell analyses of lung and nasal samples from COVID-19 patients to understand disease severity. This has driven the need for higher accuracy and throughput sequencing solutions. market players are also collaborating to develop SARS-CoV-2 targeted sequencing panels and workflows to expedite pandemic response. With resumption of research activities, growth is expected to rebound in the post pandemic years with increased funding and prioritization of precision medicine and cell therapy research.
Geographical regions with high Single Cell Genome Sequencing market share
North America currently holds the major share in the global single cell genome sequencing market owing to presence of key market players, availability of state-of-art research infrastructure and growing biotech industry. The United States accounts for a significant portion of the North American market due to heavy investments in stem cell and cancer research. Asia Pacific is emerging as the fastest growing regional market led by China, Japan and India. Expanding life sciences industry, favorable government initiatives and increasing healthcare expenditure are fueling market growth in Asia.
Rapidly growing region in the Single Cell Genome Sequencing market
Asia Pacific region is poised to witness the highest growth in the single cell genome sequencing market during the forecast period. This is attributed to rising healthcare awareness, growing genomics research in China, India and Southeast Asian countries. Regional players are launching novel sequencing platforms and assays at competitive prices to penetrate the market. Favorable funding environment for biotech startups and stem cell research is also propelling regional market expansion. Continued economic development, increasing population and healthcare reforms will further augment single cell genome sequencing adoption across Asia in the upcoming years.
For more insights, read-https://www.newsstatix.com/single-cell-genome-sequencing-market-trends-size-and-share-analysis/
